Sustained Clinical Response to Immunotherapy Followed by BET Inhibitor in a Patient with Unresectable Sinonasal NUT Carcinoma

Sustained Clinical Response to Immunotherapy Followed by BET Inhibitor in a Patient with Unresectable Sinonasal NUT Carcinoma

NUT carcinomas (NCs) are a group of rare tumors that can occur anywhere in the body and are defined by the fusion of the nuclear protein in testis (NUTM1) resulting in increased transcription of proto-oncogenes. NCs have a poor prognosis that varies according to the site of origin with an urgent nee...

Full description

Bibliographic Details
Main Authors: Harriet Herbison, Sidney Davis, David Nickless, Andrew Haydon, Malaka Ameratunga
Format: Article
Language:English
Published: Innovative Healthcare Institute 2024-02-01
Series:Journal of Immunotherapy and Precision Oncology
Subjects:
nut carcinoma
bet inhibitor
radiation
immunotherapy
Online Access:https://jipo.org/doi/pdf/10.36401/JIPO-23-19

Similar Items

Similar Items